LANXESS (DE:LXS)
XETRA:LXS
Want to see DE:LXS full AI Analyst Report?
Top Page
LANXESS
(XETRA:LXS)
Select Model
Select Model
Rating:49Neutral
Price Target:
€18.00
▲(0.67% Upside)
Action:ReiteratedDate:04/18/26
Overall score reflects weak financial performance driven by multi-year revenue decline and deepening losses, partially offset by a reasonably supported balance sheet and still-positive operating cash flow. Technical indicators add modest support (positive MACD; price above short- and mid-term averages), while valuation is constrained by negative earnings and a low dividend yield.
Positive Factors
Improved leverage
Reduced gross debt and a still-sized equity base strengthen capital structure durability. Lower absolute debt eases interest and refinancing pressure, improving optionality to fund restructuring, capex or targeted investments and helping the firm weather cyclical weakness without immediate solvency risk.
Negative Factors
Multi-year revenue decline
Sustained top-line contraction erodes scale economies and pricing leverage, pressuring gross margins and R&D or capex funding. Ongoing revenue declines make it harder to restore operating leverage and increase the risk that fixed-cost structure will keep profitability depressed over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved leverage
Reduced gross debt and a still-sized equity base strengthen capital structure durability. Lower absolute debt eases interest and refinancing pressure, improving optionality to fund restructuring, capex or targeted investments and helping the firm weather cyclical weakness without immediate solvency risk.
Read all positive factors
LANXESS (LXS) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€1.58B
Dividend Yield0.59%
Average Volume (3M)709.84K
Price to Earnings (P/E)―
Beta (1Y)1.86
Revenue Growth-6.82%
EPS Growth71.94%
CountryDE
Employees12,320
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.37
Shares Outstanding86,346,306
10 Day Avg. Volume711,662
30 Day Avg. Volume709,842
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.44
Price to Sales (P/S)0.27
P/FCF Ratio-27.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€17.40Price Target Upside-2.68% Downside
Rating ConsensusHold
Number of Analyst Covering11
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€5.81B
LANXESS Business Overview & Revenue Model
Company Description
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, additives, specialty chemicals, and plastics worldwide. It operates through four segments: Advanced Intermediates, Specialty Add...
How the Company Makes Money
LANXESS primarily makes money by manufacturing and selling specialty chemical products to business customers, generating revenue when products are delivered under customer contracts or purchase orders. Its key revenue streams are (a) specialty add...
LANXESS Earnings Call Summary
Earnings Call Date:Nov 06, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Negative
The earnings call highlighted stable performance in the Consumer Protection segment and effective cash management, along with ongoing cost and efficiency initiatives. However, significant declines in sales and EBITDA, weak demand in key segments, currency fluctuations, and geopolitical challenges indicate a challenging environment. The sentiment is further affected by the potential for job cuts and the need for structural improvements.Positive Updates
Stable Consumer Protection Segment
The Consumer Protection segment maintained stable operating income with a margin just under 16%, attributed to strategic development and acquisitions, despite increased competition.
Negative Updates
Significant Decline in Sales and EBITDA
Sales declined by 16%, with a 2% price reduction and a 6% volume decline, impacting EBITDA, which decreased from EUR 173 million in the previous year.
Read all updates
Q3-2025 Updates
Positive
Negative
Stable Consumer Protection Segment
The Consumer Protection segment maintained stable operating income with a margin just under 16%, attributed to strategic development and acquisitions, despite increased competition.
Read all positive updates
Company Guidance
During the call, LANXESS provided guidance for the remainder of the year and beyond, indicating that the company's EBITDA is expected to end at the lower end of their forecast range of EUR 520 million to CHF 580 million. This projection is influenced by a challenging economic environment, with sales declining by 16%, attributed to unfavorable currency translations, a weak American dollar, a more than 2% reduction in prices, and a 6% volume decline. The company highlighted the stability of its consumer protection segment, which maintains a high margin of just under 16%. In contrast, the Specialty Additives and Advanced Intermediates segments face difficulties due to weak demand, particularly in the building and construction industry, and fierce competition from Asia. LANXESS is implementing a cost and efficiency program to manage these challenges, aiming for structural improvements of around CHF 100 million over the coming years. The company also plans to complete its current cost-saving program of CHF 150 million by the end of the year and is preparing further measures, including potential job cuts through natural attrition, to enhance its financial position. Additionally, LANXESS is engaging with European policymakers to advocate for reforms in the European emissions trading system and competitive energy pricing to support the chemical industry.LANXESS Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
56
Neutral
Cash Flow
49
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.67B | 6.37B | 6.71B | 8.09B | 7.56B |
| Gross Profit | 1.13B | 1.30B | 1.27B | 1.94B | 1.84B |
| EBITDA | 497.00M | 543.00M | -143.00M | 865.00M | 673.00M |
| Net Income | -577.00M | -177.00M | 443.00M | 185.00M | 267.00M |
Balance Sheet | |||||
| Total Assets | 8.09B | 9.71B | 9.66B | 11.29B | 10.52B |
| Cash, Cash Equivalents and Short-Term Investments | 497.00M | 615.00M | 496.00M | 403.00M | 1.23B |
| Total Debt | 2.53B | 3.06B | 3.06B | 4.23B | 3.48B |
| Total Liabilities | 4.59B | 5.12B | 5.16B | 6.86B | 6.76B |
| Stockholders Equity | 3.50B | 4.59B | 4.50B | 4.42B | 3.76B |
Cash Flow | |||||
| Free Cash Flow | -56.00M | 188.00M | 512.00M | -248.00M | -72.00M |
| Operating Cash Flow | 263.00M | 508.00M | 838.00M | 159.00M | 407.00M |
| Investing Cash Flow | 389.00M | -263.00M | 423.00M | -1.05B | -432.00M |
| Financing Cash Flow | -518.00M | -97.00M | -1.47B | 613.00M | 389.00M |
LANXESS Technical Analysis
Positive
17.88
Price Trends
17.31
Positive
17.39
Positive
19.96
Negative
Market Momentum
0.51
Negative
55.32
Neutral
29.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:LXS, the sentiment is Positive. The current price of 17.88 is above the 20-day moving average (MA) of 16.79, above the 50-day MA of 17.31, and below the 200-day MA of 19.96, indicating a neutral trend. The MACD of 0.51 indicates Negative momentum. The RSI at 55.32 is Neutral, neither overbought nor oversold. The STOCH value of 29.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:LXS.
LANXESS Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | €4.48B | 16.33 | 16.02% | 3.91% | 1.42% | -0.40% | |
62 Neutral | €8.16B | 23.49 | 3.10% | 8.92% | -5.92% | -58.33% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | €4.85B | -1.23 | -19.52% | 3.75% | -10.63% | -23.15% | |
54 Neutral | €8.65B | 27.05 | 6.03% | 4.30% | -3.35% | -23.06% | |
49 Neutral | €1.58B | -2.64 | -14.66% | 0.59% | -6.82% | 71.94% | |
45 Neutral | €12.38B | -17.78 | -10.04% | ― | ― | ― |
* Basic Materials Sector Average
DE:LXS
LANXESS
18.06
-7.46
-29.24%
DE:BNR
Brenntag AG
59.84
3.66
6.52%
DE:1COV
Covestro
59.70
0.70
1.19%
DE:EVK
Evonik
17.50
-0.82
-4.49%
DE:FPE
Fuchs Petrolub
31.20
-1.20
-3.70%
DE:WCH
Wacker Chemie AG
95.50
28.83
43.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.